Tectonic Therapeutic (TECX)
Develops GPCR-targeted biologics for pulmonary vascular and rare vascular diseases.
$30.38
At close−0.84 (−2.69%)
Something off on this page? Send us feedback.
Next report
Nov 5, 2026
estimated · in 63 days
EPS estimate
−$1.32
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.84−$0.93−$1.07−$1.02−$1.03−$1.34−$1.18Pending
Estimate−$1.39−$1.10−$0.98−$1.05−$1.11−$1.16−$1.35−$1.32
Surprise+39.6%+15.5%−9.2%+2.9%+7.2%−15.5%+12.6%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.32 | — | — |
| Aug 2026 | −$1.35 | −$1.18 | +12.6% |
| May 2026 | −$1.16 | −$1.34 | −15.5% |
| Feb 2026 | −$1.11 | −$1.03 | +7.2% |
| Nov 2025 | −$1.05 | −$1.02 | +2.9% |
The latest year is open to everyone — the 32 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Sep 2017 | |||
| Mar 2017 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$1.32 | — | — | — | — | — | — |
| Aug 6, 2026 | −$1.35 | −$1.18 | +12.6% | — | — | — | +2.5% |
| May 7, 2026 | −$1.16 | −$1.34 | −15.5% | — | — | — | +7.9% |
| Feb 26, 2026 | −$1.11 | −$1.03 | +7.2% | — | — | — | −2.0% |
| Nov 6, 2025 | −$1.05 | −$1.02 | +2.9% | — | — | — | +1.7% |
The latest year is open to everyone — the 32 quarters behind it read with an account. Sign in | |||||||
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 20, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Sep 29, 2023 | |||||||
| Jun 29, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Sep 29, 2022 | |||||||
| Jun 29, 2022 | |||||||
| Mar 30, 2022 | |||||||
| Dec 30, 2021 | |||||||
| Sep 29, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Sep 30, 2017 | |||||||
| Mar 31, 2017 | |||||||